日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial

认知障碍与绝经前和绝经后妇女的化学内分泌治疗与内分泌治疗:RxPONDER随机临床试验的二次分析

Kang, Irene M; Forschmiedt, Jamie K; Loch, Michelle M; Lew, Danika L; Barlow, William E; Gralow, Julie R; Meric-Bernstam, Funda; Albain, Kathy S; Hayes, Daniel F; Lin, Nancy U; Perez, Edith A; Goldstein, Lori J; Rastogi, Priya; Schott, Anne F; Baehner, Rick; Sharma, Priyanka; Tripathy, Debasish; Pusztai, Lajos; Hortobagyi, Gabriel N; Kalinsky, Kevin; Henry, N Lynn

Intracranial metastases from solid tumors: Call to action and consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology collaborative

实体瘤颅内转移:神经肿瘤学会和美国临床肿瘤学会联合行动呼吁和共识

Sharma, Akanksha; Kennedy, Lucy Boyce; Van Swearingen, Amanda E D; Ahluwalia, Manmeet S; Bagley, Stephen J; Chiang, Veronica L; Chung, Caroline; Cittelly, Diana M; Daras, Mariza; Davies, Michael A; Fecci, Peter E; Haas-Kogan, Daphne A; Hattangadi-Gluth, Jona A; Jerzak, Katarzyna J; Kim, Michelle M; Malani, Rachna; Mehta, Minesh P; Moss, Nelson S; Neman, Josh; Nguyen, Don X; Priceman, Saul J; Sahebjam, Solmaz; Shih, Helen A; Soffietti, Riccardo; Wang, Nancy; Zimmer, Alexandra; Goldberg, Sarah; Khasraw, Mustafa; Anders, Carey K; Lin, Nancy U

Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer

III期炎性乳腺癌和非炎性乳腺癌的生存和治疗模式

Leone, José P; Leone, Julieta; De Placido, Pietro; Nakhlis, Faina; Schlam, Ilana; Hirko, Kelly A; Hazra, Aditi; Troll, Elizabeth; Bellon, Jennifer R; Vallejo, Carlos T; Lin, Nancy U; Tolaney, Sara M; Lynce, Filipa

Tumor genomics in patients younger than 40 years of age with metastatic breast cancer

40岁以下转移性乳腺癌患者的肿瘤基因组学

Brantley, Kristen D; Kodali, Ananya; Kirkner, Gregory J; Hughes, Melissa E; Li, Yvonne; Files, Janet; Strauss, Sarah; Feeney, Anne-Marie; Mohammed-Abreu, Ayesha; Sousa, Romualdo Barroso; Bychkovsky, Brittany; Tannenbaum, Charlotte; Loucks, Maggie; LeStage, Barbara K; King, Tari; Johnson, Bruce E; Sholl, Lynette; Dillon, Deborah; Tolaney, Sara M; Cherniack, Andrew D; Partridge, Ann H; Lin, Nancy U; Garrido-Castro, Ana C

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

定量 HER2 组织和血浆分析可预测曲妥珠单抗 deruxtecan 对乳腺癌的活性。

Tarantino Paolo, Kim Se-Eun, Hughes Melissa E, Kusmick Ross J, Smith Kalie, Brasó-Maristany Fara, Nyein Chan Nay Nwe, Paré Brunet Laia, Alder Laura, Garcia-Cortes Diana, Gomez Tejeda Zanudo Jorge, Pereslete Alyssa M, Noteware Laura, Moore Heather, Van Swearingen Amanda E D, Li Tianyu, Gupta Hersh, D'Amico Olivia, Martini Alba, Morganti Stefania, Spindel Jennifer, Cook Charmaine, McLaughlin Christine, Dvir Kathrin, Garrido-Castro Ana C, Sammons Sarah, Files Janet, Sendrick Kerry, Buck Simone, Dillon Deborah, Jeselsohn Rinath, Li Yvonne Y, Cherniack Andrew D, LoRusso Patricia, Lustberg Maryam, Vega-León Rosario, Pardo Francisco, Davis Justin, Mueller Claudius, Corgiat Brian, Curigliano Giuseppe, Anders Carey K, Petricoin Emanuel F, Rimm David L, Prat Aleix, Tayob Nabihah, Lin Nancy U, Tolaney Sara M

Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer

新辅助治疗后病理反应及个体预后对早期HER2阳性及三阴性乳腺癌患者的影响

Corti, Chiara; Li, Tianyu; Martin, Alyssa R; Hughes, Melissa E; Parker, Tonia; Duporte, Tyzaire S; Curigliano, Giuseppe; King, Tari A; Mittendorf, Elizabeth A; Lin, Nancy U; Tayob, Nabihah; Tolaney, Sara M

Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer

HER2低表达转移性三阴性乳腺癌的雄激素受体表达和免疫特征

Tarantino, Paolo; Cha, Jaeyoon; Binboga Kurt, Busem; Chu, Xiangying; Jovanović, Bojana; Zhou, Andrew; Hughes, Melissa; Russo, Douglas; DiLullo, Molly; Wrabel, Eileen; Jeselsohn, Rinath; Lin, Nancy U; Carter, Jamie; Chen, Yisang Serenity; Li, Tianyu; Tayob, Nabihah; Mittendorf, Elizabeth A; Schnitt, Stuart J; Goel, Shom; Tolaney, Sara M

The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)

新诊断的浸润性乳腺癌和导管原位癌(DCIS)患者肠道微生物组概况

Sammons, Sarah L; Kuntz, Thomas M; DiLullo, Molly; Morgan, Xochitl C; Martin, Alyssa; Hughes, Melissa E; Rahman, Tasnim; Barroso-Sousa, Romualdo; Ogayo, Esther Ritah; Giordano, Julia; Ryan, Sean; Waks, Adrienne G; Schlam, Ilana; Ligibel, Jennifer; Lin, Nancy U; Garrido-Castro, Ana C; Mittendorf, Elizabeth A; Tolaney, Sara M

The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic dissemination.

CHI3L1-中性粒细胞轴驱动免疫抑制和乳腺癌转移扩散。

Taifour Tarek, Massé Adéline, Gu Yu, Sanguin-Gendreau Virginie, Zuo Dongmei, Xiao Bin, Solymoss Emilie, Shen Yunyun, Proud Hailey, Attalla Sherif Samer, Papavasiliou Vasilios, Lin Nancy U, Hughes Melissa E, Smith Kalie, Lee Chun Geun, Kamle Suchitra, Ursini-Siegel Josie, Elias Jack A, Siegel Peter M, Jeselsohn Rinath, Muller William J